Search research articles
Contact Us
Filters
Showing results (21-30 of 89) with videos related to
Page
of 9
Sort By:
Cell Biology and Toxicology
|
March 17, 2012
Ectopic expression of Flt3 kinase inhibits proliferation and promotes cell death in different human cancer cell lines
Eystein Oveland, Line Wergeland, Randi Hovland, et al.
Tissue Engineering. Part A
|
June 25, 2014
Akt1 activity regulates vessel maturation in a tissue engineering model of angiogenesis
Monica Hellesøy, Anna L Blois, Crina E Tiron, et al.
Medchemcomm
|
August 16, 2018
Adaptive mechanisms of resistance to anti-neoplastic agents
Bibiana I Ferreira, Maria K Lie, Agnete S T Engelsen, et al.
Frontiers in Immunology
|
June 20, 2025
Axl inhibitor-mediated reprogramming of the myeloid compartment of the <i>in vitro</i> tumor microenvironment is influenced by prior targeted therapy treatment
Anisha Datta, Laura C Bahlmann, Diana N Gong, et al.
Immunity
|
February 5, 2002
Activation of the PKB/AKT pathway by ICAM-2
Omar D Perez, Shigemi Kinoshita, Yasumichi Hitoshi, et al.
Oral Oncology
|
October 29, 2011
S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrest
Dipak Sapkota, Daniela Elena Costea, Magnus Blø, et al.
Scientific Reports
|
July 12, 2024
In vivo turnover and biodistribution of soluble AXL: implications for biomarker development
Olav Tenstad, Eleni Christakou, Linn Hodneland Nilsson, et al.
Frontiers in Immunology
|
November 19, 2024
Targeting AXL cellular networks in kidney fibrosis
Sturla M Grøndal, Magnus Blø, Linn I H Nilsson, et al.
British Journal of Haematology
|
March 8, 2007
The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells
Camilla Stapnes, Anne P Døskeland, Kimberley Hatfield, et al.
Frontiers in Immunology
|
September 6, 2024
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy
Austin Rayford, Fabian Gärtner, Maria P Ramnefjell, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 89) with videos related to
Sort By:
Page
of 9
Cell Biology and Toxicology
|
March 17, 2012
Ectopic expression of Flt3 kinase inhibits proliferation and promotes cell death in different human cancer cell lines
Eystein Oveland, Line Wergeland, Randi Hovland, et al.
Tissue Engineering. Part A
|
June 25, 2014
Akt1 activity regulates vessel maturation in a tissue engineering model of angiogenesis
Monica Hellesøy, Anna L Blois, Crina E Tiron, et al.
Medchemcomm
|
August 16, 2018
Adaptive mechanisms of resistance to anti-neoplastic agents
Bibiana I Ferreira, Maria K Lie, Agnete S T Engelsen, et al.
Frontiers in Immunology
|
June 20, 2025
Axl inhibitor-mediated reprogramming of the myeloid compartment of the <i>in vitro</i> tumor microenvironment is influenced by prior targeted therapy treatment
Anisha Datta, Laura C Bahlmann, Diana N Gong, et al.
Immunity
|
February 5, 2002
Activation of the PKB/AKT pathway by ICAM-2
Omar D Perez, Shigemi Kinoshita, Yasumichi Hitoshi, et al.
Oral Oncology
|
October 29, 2011
S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrest
Dipak Sapkota, Daniela Elena Costea, Magnus Blø, et al.
Scientific Reports
|
July 12, 2024
In vivo turnover and biodistribution of soluble AXL: implications for biomarker development
Olav Tenstad, Eleni Christakou, Linn Hodneland Nilsson, et al.
Frontiers in Immunology
|
November 19, 2024
Targeting AXL cellular networks in kidney fibrosis
Sturla M Grøndal, Magnus Blø, Linn I H Nilsson, et al.
British Journal of Haematology
|
March 8, 2007
The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells
Camilla Stapnes, Anne P Døskeland, Kimberley Hatfield, et al.
Frontiers in Immunology
|
September 6, 2024
AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy
Austin Rayford, Fabian Gärtner, Maria P Ramnefjell, et al.
Page
of 9